Delivery Order SPE2DB20D2002-SPE2DB22FL47Y
- Not listed
- This federal contract award, valued at $1,743.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,555,540,832 units of Losartan Potassium 100 mg tablets, with an ultimate completion date of November 30, 2021. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the...
- This federal contract award, with a ceiling value of $2,153.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan Potassium 100 mg tablets, with a period of performance through May 26, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,456.80, is for the delivery of Losartan Potassium 100 mg tablets in 90-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order worth $1,495.76, is for the supply of 4,566,599 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price agreement. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.12 firm fixed-price delivery order is for the supply of 1,000 units of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,450.90, is a delivery order for the supply of Losartan Potassium 50 mg Tablets in 1,000-count packages. The contract has an ultimate completion date of November 29, 2024, and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $3,473.52 and is a delivery order with a firm fixed price. The contract has an ultimate completion date of September 10, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a $7,783.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,665,986 units of Losartan Potassium 100 mg tablets in 1,000-count sizes, with a completion date of April 21, 2023. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,417.99 Firm Fixed Price Delivery Order contract is for the supply of Losartan Potassium 100mg tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,981.18, is for the delivery of 4,566,250 units of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 29, 2024. This award is not associated with a...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL47YDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,114.71, is for the delivery of Losartan Potassium 100 mg Tablets in 1,000 count quantities. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/17/22 |